| Erwine's Home Health And Hospice 270 Pierce Street Suite 101, Kingston, PA, 18704 | |
| (570) 288-1013 |
News Archive
Researchers have used insight from a comprehensive genomic analysis of neuroblastoma to learn about the process driving one of the most common childhood solid tumors. The findings revealed possible approaches for developing precision medicines to improve patient outcomes. St. Jude Children's Research Hospital scientists led the study, which appears today in the journal Nature Communications.
Living in a food desert - an urban area where it is difficult to buy affordable or good-quality fresh food - means you're at increased risk to have asthma.
Genes that regulate the energy consumption of cells have a different structure and expression in type II diabetics than they do in healthy people, according to a new study from the Swedish medical university Karolinska Institutet published in Cell Metabolism.
Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
› Verified 9 days ago
| Name | Erwine's Home Health And Hospice |
|---|---|
| Location | 270 Pierce Street Suite 101, Kingston, Pennsylvania |
| Hospice ID | 391675 |
| Category | Part of a Home Health Agency |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 480 |
News Archive
Researchers have used insight from a comprehensive genomic analysis of neuroblastoma to learn about the process driving one of the most common childhood solid tumors. The findings revealed possible approaches for developing precision medicines to improve patient outcomes. St. Jude Children's Research Hospital scientists led the study, which appears today in the journal Nature Communications.
Living in a food desert - an urban area where it is difficult to buy affordable or good-quality fresh food - means you're at increased risk to have asthma.
Genes that regulate the energy consumption of cells have a different structure and expression in type II diabetics than they do in healthy people, according to a new study from the Swedish medical university Karolinska Institutet published in Cell Metabolism.
Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
› Verified 9 days ago
| NPI Number | 1588660377 |
| Organization Name | Erwines Home Health And Hospice, Inc |
| Address | 270 Pierce St Kingston, Pennsylvania, 18704 |
| Phone Number | (570)288-1013 |
News Archive
Researchers have used insight from a comprehensive genomic analysis of neuroblastoma to learn about the process driving one of the most common childhood solid tumors. The findings revealed possible approaches for developing precision medicines to improve patient outcomes. St. Jude Children's Research Hospital scientists led the study, which appears today in the journal Nature Communications.
Living in a food desert - an urban area where it is difficult to buy affordable or good-quality fresh food - means you're at increased risk to have asthma.
Genes that regulate the energy consumption of cells have a different structure and expression in type II diabetics than they do in healthy people, according to a new study from the Swedish medical university Karolinska Institutet published in Cell Metabolism.
Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.9 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 88.2 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 95.7 | 93.3 |
News Archive
Researchers have used insight from a comprehensive genomic analysis of neuroblastoma to learn about the process driving one of the most common childhood solid tumors. The findings revealed possible approaches for developing precision medicines to improve patient outcomes. St. Jude Children's Research Hospital scientists led the study, which appears today in the journal Nature Communications.
Living in a food desert - an urban area where it is difficult to buy affordable or good-quality fresh food - means you're at increased risk to have asthma.
Genes that regulate the energy consumption of cells have a different structure and expression in type II diabetics than they do in healthy people, according to a new study from the Swedish medical university Karolinska Institutet published in Cell Metabolism.
Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
› Verified 9 days ago
| Home Health Aides | 2 |
| Counselors | 0.25 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 1 |
| Physicians | 1 |
| Registered Nurses | 3 |
| Other Personnel | 1 |
| Total Employees | 9.25 |
|---|
News Archive
Researchers have used insight from a comprehensive genomic analysis of neuroblastoma to learn about the process driving one of the most common childhood solid tumors. The findings revealed possible approaches for developing precision medicines to improve patient outcomes. St. Jude Children's Research Hospital scientists led the study, which appears today in the journal Nature Communications.
Living in a food desert - an urban area where it is difficult to buy affordable or good-quality fresh food - means you're at increased risk to have asthma.
Genes that regulate the energy consumption of cells have a different structure and expression in type II diabetics than they do in healthy people, according to a new study from the Swedish medical university Karolinska Institutet published in Cell Metabolism.
Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
› Verified 9 days ago
| Others | 5 |
| Total Volunteers | 5 |
|---|
News Archive
Researchers have used insight from a comprehensive genomic analysis of neuroblastoma to learn about the process driving one of the most common childhood solid tumors. The findings revealed possible approaches for developing precision medicines to improve patient outcomes. St. Jude Children's Research Hospital scientists led the study, which appears today in the journal Nature Communications.
Living in a food desert - an urban area where it is difficult to buy affordable or good-quality fresh food - means you're at increased risk to have asthma.
Genes that regulate the energy consumption of cells have a different structure and expression in type II diabetics than they do in healthy people, according to a new study from the Swedish medical university Karolinska Institutet published in Cell Metabolism.
Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
› Verified 9 days ago
| Celtic Hospice Location: 601 Wyoming Avenue, Kingston, Pennsylvania, 18704 Phone: (570) 288-1013 |
| Erwine's Home Health And Hospice Location: 270 Pierce Street Suite 101, Kingston, Pennsylvania, 18704 Phone: (570) 288-1013 |